# OrthoSpin

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/orthospin

- Industry: Medical Devices & Equipment
- Headquarters: Yoqneam, Israel
- Website: www.orthospin.com
- Total disclosed funding: $5M
- Latest round: Series B (Mar 31, 2020)
- Investors on record: 2

## About

OrthoSpin Ltd., based in Israel, specializes in manufacturing advanced orthopedic solutions, particularly the MAXFRAME AUTOSTRUT™ System, designed for complex bone deformity corrections and limb lengthening via minimally invasive techniques.Founded in 2014 in Yoqneam, Israel, OrthoSpin Ltd. focuses on orthopedic innovations. In November 2021, DePuy Synthes Inc. acquired the company from Johnson & Johnson Innovation and Trendlines Group for USD 79.50 mn. This acquisition follows three total investment deals, with the most recent focusing on strengthening their orthopedic technology capabilities.OrthoSpin Ltd. specializes in the development and provision of advanced orthopedic solutions, primarily focusing on the MAXFRAME AUTOSTRUT™ System. This innovative system is designed to facilitate complex bone deformity corrections and limb lengthening procedures through a minimally invasive approach. The system integrates precision engineering with user-friendly features, allowing healthcare professionals to execute surgical techniques effectively while enhancing patient outcomes. Targeted primarily at orthopedic surgeons, hospitals, and clinics, OrthoSpin's devices are utilized in various regions including North America, Europe, and parts of Asia, catering to patients with specific orthopedic needs. The company emphasizes continuous improvement and innovation, ensuring that their products address the evolving challenges faced by medical practitioners and their patients.OrthoSpin Ltd. generates revenue through direct sales and partnerships with healthcare facilities and orthopedic practitioners. The transactional structure is based on unit sales of their flagship MAXFRAME AUTOSTRUT™ System, which may include initial purchase agreements and potential ongoing service agreements for maintenance and support. These transactions typically involve B2B interactions, where hospitals and clinics procure the systems for use in surgical procedures. The pricing strategy is aligned with the high-value, specialized nature of their products, reflecting the advanced technology and clinical support provided. OrthoSpin’s revenue model is designed to support sustained growth through the establishment of long-term relationships with healthcare providers, ensuring a steady demand for their innovative orthopedic solutions.Moving forward, OrthoSpin Ltd. will leverage its recent acquisition funding to enhance product development, particularly focusing on upcoming iterations of the MAXFRAME AUTOSTRUT™ System. The company aims to expand into new markets in Asia and Europe by 2023, increasing its global footprint. Additionally, the funding will be allocated to bolster marketing efforts and support the establishment of partnerships with healthcare institutions, facilitating broader access to their innovative orthopedic solutions.

## Funding rounds

- Series B, Mar 31, 2020, $5M — Johnson & Johnson Innovation, Trendlines Group

## Investors

- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series B
- Trendlines Group (https://capitalatlas.ai/funds/trendlines-group) — Series B